News Image

QIAGEN’s QuantiFERON solutions recommended for use by kidney specialists in Tunisia

Provided By GlobeNewswire

Last update: Sep 28, 2023

TUNIS, Tunisia, Sept. 28, 2023 (GLOBE NEWSWIRE) -- QIAGEN today announced that the comprehensive QuantiFERON immune response blood tests have been recommended for use by clinicians in Tunisia to help kidney disease, transplant and dialysis patients – the world’s first-ever guidance of this type by a professional body in kidney medicine.

Read more at globenewswire.com

QIAGEN N.V.

NYSE:QGEN (12/19/2025, 8:11:30 PM)

After market: 45.58 0 (0%)

45.58

+0.62 (+1.38%)



Find more stocks in the Stock Screener

Follow ChartMill for more